Evaluation of the efficacy of ZEO STENT TM plus with a 14mm diameter for the distal biliary obstruction by pancreatic cancer.

Evaluation of the efficacy of ZEO STENT TM plus with a 14mm diameter for the distal biliary obstruction by pancreatic cancer. - Evaluation of ZEO STENT TM plus.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032797

Enrollment

Registered

2018-07-01

Start date

2018-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal biliary obstruction by pancreatic cancer.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Distal biliary obstruction by pancreatic cancer 2) Expected survive more than 2 months 3) Age: >= 20 years at the time of acquiring consent 4) Written informed consent 5) ECOG Performance Status of 0-1

Exclusion criteria

Exclusion criteria: 1)Massive ascites. 2)Uncontrolled other organ diseases 3)Biliary obstruction at the hilar part. 4)Unachievable ERCP due to post-abdominal surgery state including gastrectomy. 5)Unachievable ERCP due to difficult cannulation. 6)Distal duodenal obstruction. (Post-treatment state by stent placement excluded.) 7) Inappropriate patients for study.

Design outcomes

Primary

Measure	Time frame
Rate of recurrent biliary obstruction	—

Secondary

Measure	Time frame
Stent patency duration Stent patency duration and the rate of stent function estimated by the Kaplan-Meier method Median overall survival Rate of complication Adverse events in the therapeutic period and post therapeutic period Complications related ERCP	—

Countries

Japan

Contacts

Public ContactJun Nakahodo

Cancer and Infection Disease Center Komagome Hospital Department of Gastroenterology

nakajun58@yahoo.co.jp03-3823-2101

Outcome results